Active	Status	Sponsor type	Region	Phase	Filter
6 Active 0 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Badolato, Raffaele
KIDCARES10, NCT04944979 / 2020-001496-32: Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients	Recruiting	3	30	Europe, US, RoW	Kedrion IVIG 10%	Kedrion S.p.A., Pharmaceutical company, KEDRION S.p.A, Kedrion S.p.A	Primary Immunodeficiency Disease	04/26	10/26
NEAT, NCT06193200: Evaluate the Neurological Effects of EryDex on Subjects With A-T	Recruiting	3	106	Europe, US	Dexamethasone sodium phosphate, DSP, Placebo	Quince Therapeutics S.p.A., Biotrial	Ataxia Telangiectasia	08/25	09/25
OLE_NEAT, NCT06664853: Open-Label Extension of EryDex Study IEDAT-04-2022	Recruiting	3	106	Europe, US	Dexamethasone sodium phosphate	Quince Therapeutics S.p.A., Biotrial	Ataxia Telangiectasia	11/26	11/26
NCT05082285 / 2021-001367-24: A Study on the Safety, Tolerability and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Infants	Active, not recruiting	2	724	Europe, RoW	MenABCWY-2Gen low dose vaccine, MenABCWY-2Gen high dose vaccine, MenABCWY-1Gen vaccine, MenB vaccine, Bexsero, MenACWY-TT vaccine, Nimenrix	GlaxoSmithKline	Infections, Meningococcal	03/25	03/25